Abate Kristin sold KPTI
January 28, 2026 · Form 4 insider transaction
Abate Kristin sold 50 shares of Karyopharm Therapeutics Inc. at $7.03 per share, a transaction worth $351.50. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
50
Price
$7.03
Total value
$351.50
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 28, 2026
Filing dateJanuary 29, 2026
Shares owned after22,622
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.